IRCT201010124920N1
Completed
未知
A therapeutic and side effects’ comparison between Reditux and brand type (MabThera) in Diffuse Large B Cell Lymphoma (DLBCL)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diffuse large B cell lymphoma (DLBCL).
- Sponsor
- Cinnagen Company
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •DLBCL patients 18 to 65 years old (male \& female); CD 20 marker positivity; Completion of informal consent. Exclusion criteria: Recurrence DLBCL; Systolic dysfunction (EF\<50%); HIV, HBV, HCV markers positivity; History of organ transplantation of other active malignancy; History of allergy to monoclonal antibodies; ECOG performance status \>3; Advanced Liver or renal dysfunctions (Bil T \>6 mg/dl or Cr \>4 mg/dl).
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A therapeutic and side effects comparison between domestic type and the similar brand in gastric cancer.Gasteric cancer.Malignant neoplasm of stomachIRCT2014061118061N1Behin Tamin Rosamed Co.60
Not yet recruiting
Phase 4
To compare the effects of local application of hyaluronic acid gel and chlorhexidine gel in treatment of patients with gum disease.Health Condition 1: B998- Other infectious diseaseCTRI/2019/01/017269Dr JAAHNAVI LANKA
Completed
Not Applicable
HAART studyHIV/AIDSPACTR201312000661337ABUTH198
Completed
Not Applicable
Comparative Analysis of Therapeutic Effect Between Theranova Dialyzer and High Flux Dialyzer Using OMICSDiseases of the genitourinary systemKCT0004130Pusan National University Hospital20
Not yet recruiting
Phase 1
Effects of Ultrasound and Fluoroscopy guided injection in Ankylosing Spondylitis and related diseases.CTRI/2020/07/026854R G Kar Medical College and Hospital